Protective Effect of Ticagrelor Against Infective Endocarditis Induced by Virulent Staphylococcus aureus in Mice

被引：5

作者：

Oury, Cecile ^{[1
,2
,11
,12
]}

Meyers, Severien ^{[3
]}

Jacques, Nicolas ^{[1
,2
]}

Leeten, Kirsten ^{[1
,2
]}

Jiang, Zheshen ^{[1
,2
]}

Musumeci, Lucia ^{[1
,2
]}

Lox, Marleen ^{[3
]}

Debuisson, Margaux ^{[2
]}

Goffin, Eric ^{[4
]}

Pirotte, Bernard ^{[4
]}

Delvenne, Philippe ^{[5
,6
]}

Nchimi, Alain ^{[1
,2
]}

Hubert, Cedric ^{[7
]}

Heptia, Melanie ^{[7
]}

Hubert, Philippe ^{[7
]}

Kuijpers, Marijke J. E. ^{[8
]}

Vanassche, Thomas ^{[3
]}

Martinod, Kimberly ^{[3
]}

Verhamme, Peter ^{[3
]}

Lancellotti, Patrizio ^{[1
,2
,9
,10
]}

机构：

[1] Univ Liege Hosp, GIGA Inst, Ctr Hosp Univ CHU Liege, Lab Cardiol, Liege, Belgium

[2] Univ Liege Hosp, Ctr Hosp Univ CHU Liege, Dept Cardiol, Liege, Belgium

[3] Univ Leuven, Ctr Mol & Vasc Biol, Dept Cardiovasc Sci, Leuven, Belgium

[4] Univ Liege, Ctr Interdisciplinary Res Med CIRM, Ctr Hosp Univ, Lab Med Chem, Liege, Belgium

[5] Univ Liege, Ctr Hosp Univ Liege, Dept Pathol, Liege, Belgium

[6] Univ Liege, GIGA Inst, Lab Expt Pathol, Liege, Belgium

[7] Univ Liege, Lab Pharmaceut Analyt Chem, CIRM, Liege, Belgium

[8] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands

[9] Maria Cecilia Hosp Cotignola, Grp Villa Maria Care & Res, Bari, Italy

[10] Anthea Hosp, Bari, Italy

[11] Univ Liege Hosp, GIGA Inst, Ctr Hosp Univ CHU Liege, Lab Cardiol, Ave Hop 1,B34, B-4000 Liege, Belgium

[12] Univ Liege Hosp, Ctr Hosp Univ CHU Liege, Dept Cardiol, Ave Hop 1,B34, B-4000 Liege, Belgium

来源：

JACC-BASIC TO TRANSLATIONAL SCIENCE | 2023年 / 8卷 / 11期

关键词：

bacterial virulence; infective endocarditis; Staphylococcus aureus; ticagrelor; CLUMPING FACTOR; PLUS ASPIRIN; MECHANISMS; THROMBOSIS; RISK;

D O I：

10.1016/j.jacbts.2023.02.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In addition to its potent antiplatelet activity, ticagrelor possesses antibacterial properties against gram-positive bacteria. We wondered whether the typical clinical dosage of ticagrelor could prevent the development of infective endocarditis caused by highly virulent Staphylococcus aureus. Ticagrelor prevented vegetation formation in a mouse model of inflammation-induced endocarditis. The dosage achieved in patients under ticagrelor therapy altered bacterial toxin production and adherence on activated endothelial cells, thereby mitigating bacterial virulence. Besides the previously described bactericidal activity at high doses, ticagrelor at typical clinical doses possesses antivirulence activity against S aureus. Ticagrelor antiplatelet activity further interferes with the interplay between platelets and bacteria.

引用

页码：1439 / 1453

页数：15

共 37 条

[1] Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS
Baber, Usman
Dangas, George
Angiolillo, Dominick Joseph
Cohen, David Joel
Sharma, Samin Kumar
Nicolas, Johny
Briguori, Carlo
Cha, Jin Yu
Collier, Timothy
Dudek, Dariusz
Dzavik, Vladimir
Escaned, Javier
Gil, Robert
Gurbel, Paul
Hamm, Christian W.
Henry, Timothy
Huber, Kurt
Kastrati, Adnan
Kaul, Upendra
Kornowski, Ran
Krucoff, Mitchell
Kunadian, Vijay
Marx, Steven Owen
Mehta, Shamir
Moliterno, David
Ohman, Erik Magnus
Oldroyd, Keith
Sardella, Gennaro
Sartori, Samantha
Shlofmitz, Richard
Steg, Philippe Gabriel
Weisz, Giora
Witzenbichler, Bernhard
Han, Ya-Ling
Pocock, Stuart
Gibson, Charles Michael
Mehran, Roxana
[J]. EUROPEAN HEART JOURNAL, 2020, 41 (37) : 3533 - 3545
[2] Secreted Immunomodulatory Proteins of Staphylococcus aureus Activate Platelets and Induce Platelet Aggregation
Binsker, Ulrike
Palankar, Raghavendra
Wesche, Jan
Kohler, Thomas P.
Prucha, Josephine
Burchhardt, Gerhard
Rohde, Manfred
Schmidt, Frank
Broeker, Barbara M.
Mamat, Uwe
Pane-Farre, Jan
Graf, Anica
Ebner, Patrick
Greinacher, Andreas
Hammerschmidt, Sven
[J]. THROMBOSIS AND HAEMOSTASIS, 2018, 118 (04) : 745 - 757
[3] Localized endothelial-based control of platelet aggregation and coagulation under flow: A proof-of-principle vessel-on-a-chip study
Brouns, Sanne L. N.
Provenzale, Isabella
van Geffen, Johanna P.
van der Meijden, Paola E. J.
Heemskerk, Johan W. M.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (04) : 931 - 941
[4] Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall
Claes, J.
Liesenborghs, L.
Peetermans, M.
Veloso, T. R.
Missiakas, D.
Schneewind, O.
Mancini, S.
Entenza, J. M.
Hoylaerts, M. F.
Heying, R.
Verhamme, P.
Vanassche, T.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (05) : 1009 - 1019
[5] Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, Seth W.
Cheung, Gordon Y. C.
Otto, Michael
[J]. NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (07) : 457 - 471
[6] Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria
Hannachi, Nadji
Oge-Ganaye, Emma
Baudoin, Jean-Pierre
Fontanini, Anthony
Bernot, Denis
Habib, Gilbert
Camoin-Jau, Laurence
[J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
[7] Aspirin Effect on Staphylococcus aureus-Platelet Interactions During Infectious Endocarditis
Hannachi, Nadji
Habib, Gilbert
Catnoin-Jau, Laurence
[J]. FRONTIERS IN MEDICINE, 2019, 6
[8] Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis:: FnBPA is sufficient to activate human endothelial cells
Heying, Ruth
van de Gevel, Joke
Que, Yok-Ai
Moreillon, Philippe
Beekhuizen, Henry
[J]. THROMBOSIS AND HAEMOSTASIS, 2007, 97 (04) : 617 - 626
[9] Infective endocarditis
Holland, Thomas L.
Baddour, Larry M.
Bayer, Arnold S.
Hoen, Bruno
Miro, Jose M.
Fowler, Vance G., Jr.
[J]. NATURE REVIEWS DISEASE PRIMERS, 2016, 2
[10] α-hemolysin of Staphylococcus aureus impairs thrombus formation
Jahn, Kristin
Handtke, Stefan
Palankar, Raghavendra
Kohler, Thomas P.
Wesche, Jan
Wolff, Martina
Bayer, Janina
Wolz, Christiane
Greinacher, Andreas
Hammerschmidt, Sven
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (06) : 1464 - 1475

← 1 2 3 4 →